Why Cal-Maine Foods Stock Cracked on Monday

Cal-Maine Foods fell as much as 4.5% intraday after reports that the U.S. Department of Justice may sue major egg producers, including Cal-Maine, over alleged price fixing tied to the Expana pricing service. Egg prices peaked above $6 a dozen last year but are already down about 45%, which may limit the case's longer-term financial impact. The bigger fundamental concern is profit normalization, with net income forecast to drop from $1.2 billion last year to below $200 million over the next two years.

Analysis

This is less a clean litigation overhang than a regime-change trade in a highly cyclical commodity. The market is pricing a legal headline, but the bigger earnings driver is that egg margins are mean-reverting hard as flock rebuilding and normalizing supply overpower the prior scarcity shock. That means the equity risk is not a one-day DOJ discount; it is that forward earnings power is getting pulled down just as the market is re-rating away the scarcity premium.

The second-order effect is that any antitrust scrutiny accelerates retailer and distributor caution around procurement concentration, which can pressure Cal-Maine’s pricing power even if no case is filed. If benchmarks like Expana become politically toxic, the industry may move to less transparent pricing, but in the near term that usually means weaker realized pricing, not stronger margins. The key timeline is months, not days: legal uncertainty can linger, while the fundamental reset in egg prices can reprice within quarters.

The contrarian miss is that the stock may still be too expensive on normalized earnings. When profits revert from a windfall year to something closer to base-rate economics, a “cheap” P/E can be a value trap; commodity producers often look optically inexpensive right before consensus cuts catch up. The DOJ story is useful mainly because it keeps multiple compression alive while the real earnings downdraft is already underway.

Key Decisions for Investors

• Short CALM on any strength over the next 1-4 weeks; treat DOJ headlines as a catalyst for temporary bounces, but the core thesis is earnings normalization, not litigation settlement value.
• Buy CALM put spreads 3-6 months out to capture both multiple compression and forecast cuts; use a defined-risk structure because legal outcomes can create sharp bear-market squeezes.
• If already long commodities, pair long quality industrial/ag names against short CALM to isolate the supply-normalization trade rather than betting on the legal process.
• Avoid adding to CALM until consensus EPS resets lower; the risk/reward is unfavorable once the market starts underwriting sub-$200M forward net income.